- Home
- INDV vs BGM Comparison
INDV vs BGM Comparison
Compare INDV & BGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDV
- BGM
- Stock Information
- Founded
- INDV 1994
- BGM 2019
- Country
- INDV United States
- BGM China
- Employees
- INDV N/A
- BGM N/A
- Industry
- INDV Biotechnology: Pharmaceutical Preparations
- BGM
- Sector
- INDV Health Care
- BGM
- Exchange
- INDV Nasdaq
- BGM NYSE
- Market Cap
- INDV 1.2B
- BGM 1.0B
- IPO Year
- INDV N/A
- BGM 2021
- Fundamental
- Price
- INDV $11.08
- BGM $11.03
- Analyst Decision
- INDV Strong Buy
- BGM
- Analyst Count
- INDV 2
- BGM 0
- Target Price
- INDV $14.50
- BGM N/A
- AVG Volume (30 Days)
- INDV 939.2K
- BGM 30.9K
- Earning Date
- INDV 04-24-2025
- BGM 05-20-2025
- Dividend Yield
- INDV N/A
- BGM N/A
- EPS Growth
- INDV N/A
- BGM N/A
- EPS
- INDV N/A
- BGM N/A
- Revenue
- INDV $1,170,000,000.00
- BGM $25,097,951.00
- Revenue This Year
- INDV N/A
- BGM N/A
- Revenue Next Year
- INDV $4.26
- BGM N/A
- P/E Ratio
- INDV N/A
- BGM N/A
- Revenue Growth
- INDV 4.09
- BGM N/A
- 52 Week Low
- INDV $7.33
- BGM $2.70
- 52 Week High
- INDV $18.59
- BGM $14.78
- Technical
- Relative Strength Index (RSI)
- INDV 56.35
- BGM 50.51
- Support Level
- INDV $10.91
- BGM $10.17
- Resistance Level
- INDV $12.26
- BGM $11.82
- Average True Range (ATR)
- INDV 0.47
- BGM 0.63
- MACD
- INDV 0.03
- BGM -0.03
- Stochastic Oscillator
- INDV 66.95
- BGM 54.21
About INDV Indivior PLC
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.
About BGM QILIAN INTERNATIONAL HLDG GROUP LTD
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.